Showing results (311-320 of 1,340) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trialByram H Ozer, Adam L Cohen, Howard Colman, et al.Neuro-Oncology Advances|March 25, 2026
Rare germline variants contribute to glioma predisposition: Whole-genome analysis of a regional cohort of glioma patientsAdam Rosenbaum, Carl Wibom, Austin Hammermeister Suger, et al.Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.Neuro-Oncology Advances|May 8, 2026
Higher perioperative dexamethasone exposure is associated with shorter survival in glioblastomaSeverin Rüssli, Claire Descombes, Alexis P R Terrapon, et al.Neuro-Oncology Advances|June 18, 2026
Sonobiopsy for enrichment of circulating microRNAs in glioma patientsJinyun Yuan, Yuanxiang Li, Chih-Yen Chien, et al.Neuro-Oncology Advances|June 17, 2026
Sensitivity and specificity of cerebrospinal fluid placental alkaline phosphatase in germinoma: An 8 pg/mL thresholdKentaro Chiba, Yasuo Aihara, Yuichi Oda, et al.Neuro-Oncology Advances|July 10, 2020
Label-free multiphoton imaging allows brain tumor recognition based on texture analysis-a study of 382 tumor patientsOrtrud Uckermann, Roberta Galli, Georg Mark, et al.Neuro-Oncology Advances|July 10, 2020
MRI image analysis methods and applications: an algorithmic perspective using brain tumors as an exemplarVachan Vadmal, Grant Junno, Chaitra Badve, et al.Neuro-Oncology Advances|December 3, 2021
Precision medicine biomarkers in brain metastases: applications, discordances, and obstaclesAriane Steindl, Priscilla K Brastianos, Matthias Preusser, et al.Neuro-Oncology Advances|December 3, 2021
The microenvironment of brain metastases from solid tumorsEthan S Srinivasan, Krutika Deshpande, Josh Neman, et al.Pageof 134